Status:

COMPLETED

Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis

Lead Sponsor:

Ra Pharmaceuticals, Inc.

Conditions:

Myasthenia Gravis, Generalized

Eligibility:

All Genders

18-74 years

Phase:

PHASE3

Brief Summary

The RAISE study is a multicenter, randomized, double-blind, placebo controlled study to confirm the efficacy, safety, and tolerability of zilucoplan in subjects with generalized Myasthenia Gravis. Sub...

Eligibility Criteria

Inclusion

  • Diagnosis of gMG \[Myasthenia Gravis Foundation of America (MGFA) Class II-IV\] at Screening
  • Positive serology for acetylcholine receptor (AChR) autoantibodies
  • MG-ADL Score of ≥ 6 at Screening and Baseline
  • QMG score ≥ 12 at Screening and Baseline
  • No change in corticosteroid dose for at least 30 days prior to Baseline or anticipated to occur during the 12-week Treatment Period
  • No change in immunosuppressive therapy, including dose, for at least 30 days prior to Baseline or anticipated to occur during the 12-week Treatment Period

Exclusion

  • Thymectomy within 12 months prior to Baseline or scheduled to occur during the 12 week Treatment Period
  • History of meningococcal disease
  • Current or recent systemic infection within 2 weeks prior to Baseline or injection requiring intravenous (IV) antibiotics within 4 weeks prior to Baseline

Key Trial Info

Start Date :

September 17 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 30 2021

Estimated Enrollment :

174 Patients enrolled

Trial Details

Trial ID

NCT04115293

Start Date

September 17 2019

End Date

December 30 2021

Last Update

July 16 2025

Active Locations (77)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 20 (77 locations)

1

Site 41: Diagnostic and Medical Clinic

Mobile, Alabama, United States, 36604

2

Site 116: Neuromuscular Clinic and Research Center

Phoenix, Arizona, United States, 85028

3

Site 4: University of Southern California

Los Angeles, California, United States, 90033

4

Site 31: University of California Irvine

Orange, California, United States, 92868